Kura Oncology, Inc.KURANASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-60.17%
↓ 98% vs avg
Percentile
P21
Within normal range
Streak
3 yr
Consecutive declineDecelerating
Average
-30.36%
Historical baseline
PeriodValue
2025-60.17%
2024-13.99%
2023-12.36%
2022-4.12%
2021-45.57%
2020-41.95%
2019-4.46%
2018-70.59%
2017-28.57%
2016-21.81%